Congenital Hematological Disorder Completed Phase 3 Trials for Vatreptacog alfa (DB12409)
Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder
| Indication | Status | Phase |
|---|---|---|
| DBCOND0081791 (Congenital Hematological Disorder) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01392547 | Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors | Treatment |